Pasar al contenido principal

Conexión rápida

Join us to explore how our API expertise can help you drive success

April 17Th - 19Th, 2024
|
East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan

Contact Us
Verified

Our Team at CPHI Japan 2024

About CPHI Japan 2024

CPHI Japan 2024 is a leading annual trade event focusing on the pharmaceutical industry in Japan. Held at the Tokyo Big Sight (East Halls 4, 5 & 6) from April 17th to 19th, 2024, the event brings together a comprehensive range of exhibitors and attendees from across the pharmaceutical supply chain.

Attendees can expect to:

  • Explore the latest advancements and solutions showcased by exhibitors covering pharma ingredients, outsourcing services, biopharmaceuticals, pharmaceutical machinery & equipment, and drug delivery systems & packaging.
  • Network with industry professionals from Japan and around the world, fostering potential business partnerships.
  • Gain valuable knowledge through conferences and presentations delivered by industry experts, staying abreast of current trends and insights within the Japanese pharmaceutical market.

CPHI Japan 2024 serves as a platform for industry stakeholders to connect, exchange information, and explore business opportunities within the Japanese pharmaceutical landscape.

 

About Dr.Reddy's API Business

We specialise in manufacturing and supplying a wide range of APIs for generic formulation manufacturers in India and overseas. The company has a diversified portfolio of 180+ active pharmaceutical ingredients, which are used in major therapeutic areas such as gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Our API manufacturing facilities adhere to cGMP (ICH Q7) and are inspected on a regular basis by international regulatory bodies. We have eight commercially inspected USFDA production plants, six in India and one each in Mexico and the United Kingdom

About Graph

About Graph

Dr. Reddy's API business operates in a number of global markets, including the United States of America, Latin America, Europe, India, Russia, and other CIS nations.

ENQUIRE NOW

Sustainability

Dr. Reddy's is among the top sustainable pharmaceutical companies globally. We are listed in the sustainability yearbook of S&P 2022 for the second year in a row and the Bloomberg Gender-Equality Index (GEI) for the fifth consecutive year. In addition, we were ranked ninth in the Dow Jones Sustainability Index (DJSI) 2021 among the most sustainable pharmaceutical companies in the world. In our sustainability journey, these accolades are humbling and demonstrate that we're on the right track. These awards recognize our consistent performance in the environment, social, and governance (ESG) framework. Sustainability and ESG are becoming increasingly important topics for all stakeholders, so we will strive to maintain visibility in these areas.

Sustainability

Our Achievements

Our Plants

Dr. Reddy’s API  Manufacturing Locations

Company

© 2024 Dr. Reddy’s Laboratories Ltd. All rights reserved.

Renuncia

Ninguna información en este catálogo, incluida cualquier referencia a cualquier producto o servicio, constituye una oferta de venta, ni debe interpretarse como representación de una oferta de venta. Los productos protegidos por patentes válidas no se ofrecen ni se suministran para uso comercial. Sin embargo, las cantidades de investigación de dichos productos pueden ofrecerse con el fin de presentaciones reglamentarias, siempre que existan dichas exenciones reglamentarias. Los compradores deben realizar una evaluación independiente del escenario de la patente para sus respectivos mercados y serán responsables de todas las responsabilidades relacionadas con la patente. Los productos protegidos por patentes válidas en la India no están disponibles para uso comercial, pero estarían disponibles para los fines de la Sección 107A.